Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER

Deepverge's Labskin joins US govt consortium developing new radiation exposure tests

Stock Markets Oct 04, 2022 07:40
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
Deepverge's Labskin joins US govt consortium developing new radiation exposure tests
 
DVRG
0.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Deepverge PLC (LON:DVRG) said its Labskin arm has been selected by the US national intelligence office to help develop new ways to evaluate radiation exposure in civilians and the military.

The company will get US$810,000 over a three-year period, starting immediately, for its work in developing technology for minimally invasive radiation testing in a programme known as TEI-REX, standing for targeted evaluation of ionizing radiation exposure.

Labskin will be part of a multidisciplinary consortium set up by the Intelligence Advanced Research Projects Activity (IARPA), the research and development arm of the US Office of the Director of National Intelligence, which also includes professors and scientists from the University of Columbia, Georgetown University, the Georgia Institute of Technology, American Type Culture Collection, and researchers from ARETE Associates, a defence contractor specialising in sensing solution and machine learning algorithms.

The TEI-REX program aims to establish novel approaches for evaluation of individuals or organisms exposed to low-dose ionizing radiation or ‘biodosimetry’, according to IARPA’s website, which it says will be accomplished through analysis of samples collected minimally or non-invasively, to include hair, skin, sweat, and saliva.

Radiation biodosimetry technologies are designed to measure the amount of biological effect or damage to biological tissues from ionizing radiation

A new biodosimetry standard developed by the consortium could be applied to maintain the safety of military and civilian populations working or living in close proximity to ionizing radiation sources, such as: nuclear plants, nuclear vessels, ammunition, etc.

Deepverge said Labskin, coupled with its Skin Trust Club's expertise in skin research and microbiology, is “essential for the project” as it will create a simple non-invasive swab test to collect signatures from the skin surface that allows machine learning algorithms to detect and quantify the impact of any amount of radiation exposure on the skin microbiome.

Labskin is a 3D human skin equivalent test platform that is used to prove the impact of skincare product claims in healthcare, life sciences, skin microbiome clinical trials, pharmaceutical and cosmetics industries.

David Caballero-Lima, chief scientist at Labskin, said the same technique can also be applied to detect the impact of pollution or a variety of chemicals on the environment, and could also be used to detect exposure in complex ecological systems such as the soil, crops or sediments.

“This is a unique opportunity to revolutionise the way we test for radiation exposure. Labskin and Skin Trust Club are at the forefront of an increasing number of cutting edge technologies that are changing our world,” he said.

Colin O'Sullivan, Labskin’s chief information officer, said, “the inclusion of artificial intelligence and the opportunity to work with ARETE Associates, with their vast experience in complex AI applications, will result in further advances in how AI can be used in conjunction with our skin model at scale”.

He noted that the project coincides with the expansion of Labskin’s US labs in Delaware, which will assist in the implementation of what is expected to be a large project.

“We believe our proven ability to transition technology to the field with Skin Trust Club will be invaluable as we progress this project," he said.

Read more on Proactive Investors UK

Disclaimer

Deepverge's Labskin joins US govt consortium developing new radiation exposure tests
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email